Iatrogenic Thyrotoxicosis: Definition and Clinical Manifestations
What Is Iatrogenic Thyrotoxicosis?
Iatrogenic thyrotoxicosis is a state of excessive circulating thyroid hormone that results from medical interventions rather than endogenous thyroid gland overproduction. This condition differs fundamentally from primary hyperthyroidism because the thyroid gland itself is not hyperactive—instead, the excess hormone comes from external sources or medical treatments 1.
The three main mechanisms causing iatrogenic thyrotoxicosis are:
- Excessive thyroid hormone ingestion ("thyrotoxicosis factitia")—either intentional overdose or unintentional overtreatment with levothyroxine 1, 2
- Thyroid gland destruction with hormone release—from radiation therapy, lymphocytic infiltration, or physical trauma causing preformed hormones to leak into circulation 1
- Iodine-induced hyperthyroidism—from radiologic contrast agents, topical antiseptics, or medications like amiodarone that trigger actual thyroid hormone production 1
The most common cause in clinical practice is levothyroxine overtreatment, which accounts for approximately half of all low TSH events in community-dwelling adults 3. This occurs when patients receive doses that suppress TSH below the normal range, creating a state of exogenous subclinical or overt hyperthyroidism 2, 3.
Clinical Symptoms of Iatrogenic Thyrotoxicosis
Cardiovascular Manifestations
The cardiovascular system is particularly vulnerable to excess thyroid hormone:
- Palpitations and tachycardia—resting heart rate typically exceeds 90-100 bpm due to increased cardiac output and enhanced adrenergic sensitivity 4, 2
- Atrial fibrillation—risk increases 3-5 fold, especially in patients over 60 years or those with pre-existing cardiac disease 2, 3
- Cardiovascular compromise—in severe cases (thyroid storm), patients develop hemodynamic instability requiring intensive management 4
- Increased cardiac workload—manifesting as dyspnea, exercise intolerance, or angina in susceptible individuals 2
Neuropsychiatric Symptoms
- Tremor—fine tremor of the hands is characteristic, reflecting increased adrenergic tone 2
- Anxiety and restlessness—patients report feeling "wired" or unable to relax 2
- Mental status changes—in severe thyrotoxicosis, confusion, agitation, or even psychosis can develop 4, 2
- Insomnia—difficulty falling asleep or staying asleep is common 2
Metabolic and Constitutional Features
- Weight loss despite normal or increased appetite—accelerated metabolism causes tissue catabolism 2
- Heat intolerance and excessive sweating—patients feel uncomfortably warm and perspire easily 2
- Muscle weakness—particularly affecting proximal muscles (thighs, shoulders) 2
- Fatigue—paradoxically, despite hypermetabolism, patients often report exhaustion 2
Gastrointestinal Symptoms
- Increased bowel frequency or diarrhea—accelerated gut motility is typical 2
- Nausea—can occur in acute presentations 4
Severe Presentation: Thyroid Storm
When iatrogenic thyrotoxicosis becomes life-threatening, it manifests as thyroid storm, characterized by:
- Extreme hyperthermia (temperature >40°C/104°F) 4
- Cardiovascular collapse—severe tachycardia, heart failure, or shock 4
- Altered mental status—ranging from severe agitation to coma 4, 2
- Multi-organ dysfunction—requiring intensive care unit management 4
Diagnostic Confirmation
Laboratory findings that confirm iatrogenic thyrotoxicosis include:
- Suppressed or undetectable TSH (<0.1 mIU/L) 2, 3
- Elevated free T4 and/or free T3—in one reported case, total T3 reached 525 ng/dL (normal 80-200) and free T3 was 28 pg/mL (normal 2.0-3.5) 4
- History of thyroid hormone ingestion or recent medical intervention (radiation, iodine exposure, amiodarone) 1, 4
Critical Clinical Pitfalls
Distinguishing From Endogenous Hyperthyroidism
The key distinction is that iatrogenic thyrotoxicosis results from external hormone sources or gland destruction, not autonomous thyroid overproduction 1. Radioiodine uptake scans show low uptake in iatrogenic cases (because the gland is suppressed or destroyed), whereas Graves' disease shows high uptake 1.
Recognizing Silent Overtreatment
Approximately 25% of patients on levothyroxine are unintentionally maintained on doses that fully suppress TSH, yet many remain asymptomatic while incurring cardiac and skeletal damage 2, 3. This "silent" thyrotoxicosis is particularly dangerous because:
- Atrial fibrillation risk increases even without overt symptoms 2, 3
- Bone mineral density declines progressively, especially in postmenopausal women 2, 3
- Cardiovascular mortality rises up to 3-fold in individuals over 60 years 2
High-Risk Populations
Elderly women face the highest risk of iatrogenic thyrotoxicosis, with thyroid hormone initiation rates reaching 3 per 100 person-years in women over 80 3. This group is particularly vulnerable to atrial fibrillation and osteoporotic fractures from even mild TSH suppression 3.
Management Principles
Immediate Actions for Severe Cases
For thyroid storm or severe thyrotoxicosis with cardiovascular compromise, therapeutic plasma exchange (TPE) can rapidly remove protein-bound thyroid hormone when medical therapy fails 4. In one case, a single plasma volume exchange achieved 37% extraction efficiency and restored near-normal mental status within hours 4.
Standard Medical Management
Treatment focuses on four targets:
- Prevent new hormone synthesis—using thionamides (methimazole, propylthiouracil) 1
- Block hormone release—with iodine solutions or lithium 1
- Prevent peripheral conversion—using corticosteroids or beta-blockers 1
- Stabilize adrenergic tone—with beta-blockers to control heart rate and tremor 1
Levothyroxine Overtreatment
When iatrogenic thyrotoxicosis results from excessive levothyroxine, immediately reduce the dose by 25-50 mcg if TSH <0.1 mIU/L, or by 12.5-25 mcg if TSH is 0.1-0.45 mIU/L 2. Recheck TSH and free T4 in 6-8 weeks to confirm normalization 2.
Amiodarone-Induced Thyrotoxicosis
This represents the most challenging form of iatrogenic thyrotoxicosis, often requiring close collaboration between endocrinologists and surgeons 1. Surgical thyroidectomy may be life-saving when medical management fails, though this role is frequently underestimated 1.
Long-Term Consequences of Untreated Iatrogenic Thyrotoxicosis
Even mild, asymptomatic TSH suppression carries serious morbidity risks:
- Atrial fibrillation—occurs at rates of 17.7 per 1000 person-years in treated patients versus 1.5 per 1000 in untreated individuals 3
- Osteoporosis and fractures—particularly hip and vertebral fractures in women over 65 2, 3
- Cardiovascular mortality—increases significantly in older adults with chronic TSH suppression 2
For one-third of overtreated patients, TSH suppression persists for at least two years, indicating that this is not a transient problem but a chronic management failure 3.